Kl. Yeo et al., Outcomes of extremely premature infants related to their peak serum bilirubin concentrations and exposure to phototherapy, PEDIATRICS, 102(6), 1998, pp. 1426-1431
Objectives. To analyze,in extremely low birth weight infants, associations
between peak bilirubin concentration and evidence of brain damage, and betw
een peak bilirubin concentration and blindness attributable to retinopathy
of prematurity.
Methods. Retrospective study of 128 infants of less than or equal to 800 g
birth weight and less than or equal to 27 weeks gestation born between 1980
and 1989 and discharged from a tertiary neonatal intensive care unit. Afte
r screening analyses, multivariable analyses were conducted to identify ass
ociations between blindness and peak bilirubin concentration (dichotomized
at different levels to create 3 binary variables), and between severe adver
se neurodevelopmental outcome at 18 months postterm age and peak bilirubin
levels.
Results. Of 128 18-month survivors, 15 had severe visual loss attributable
to retinopathy of prematurity, 21 had neurodevelopmental deficit, and 5 wer
e deaf. Visual loss was significantly associated with low-peak serum biliru
bin concentration (<9.4 mg/dL (<160 mu mol/L) versus greater than or equal
to 9.4 mg/dL (odds ratio [OR] confidence interval [CII 4.48 [1.15-17.43])),
low gestational age (OR [CII per week 1.95 [1.05-3.63]), and longer durati
on of phototherapy (OR [CI] per 10 hours 1.17 [1.02-1.33]). The association
of neurodevelopmental impairment with grades 3 and 4 intraventricular hemo
rrhage was statistically significant (OR 5.39 [1.83-15.84]), but with high-
peak serum bilirubin concentration greater than or equal to 11.7 mg/dL (gre
ater than or equal to 200 mu mol/L), was not significant (OR 2.89 [0.87-9.5
3]).
Conclusions. In these infants, prolonged phototherapy and low-peak serum bi
lirubin concentrations were associated with severe visual loss attributable
to retinopathy of prematurity. The findings should be interpreted with cau
tion until the evidence is reinforced in other patient populations.